Schizophrenia Research
Volume 101, Issue 1 , Pages 273-286 , April 2008

Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: Prospective data from phase 1

  • Jonathan M. Meyer

      Affiliations

    • Department of Psychiatry, University of California, San Diego, United States
    • VA San Diego Healthcare System, United Statess
    • Corresponding Author InformationCorresponding author. San Diego VAMC, 3350 La Jolla Village Drive (116A), San Diego, CA 92161, United States. Tel.: +1 858 642 3570; fax: +1 858 552 7542.
    • ,
  • Vicki G. Davis

      Affiliations

    • Department of Biostatistics, Collaborative Studies Coordinating Center, University of North Carolina at Chapel Hill, Bank of America Center, 137 E. Franklin Street, Suite 400, Chapel Hill, NC 27514-4145, United States
    • ,
  • Donald C. Goff

      Affiliations

    • Department of Psychiatry, Harvard University, United States
    • Schizophrenia Program, Massachusetts General Hospital, Freedom Trail Clinic, Lindemann Mental Health Center, 25 Staniford St., Boston, MA 02114, United States
    • ,
  • Joseph P. McEvoy

      Affiliations

    • Department of Psychiatry and Behavioral Sciences, Duke University, United States
    • Clinical Research, John Umstead Hospital, 1003 12th Street, Butner, NC 27509, United States
    • ,
  • Henry A. Nasrallah

      Affiliations

    • Psychiatry and Neuroscience, University of Cincinnati, 231 Albert Sabin Way, PO Box 670559, Cincinnati, OH 45267-0559, United States
    • ,
  • Sonia M. Davis

      Affiliations

    • Biostatistics, Quintiles Inc., 5927 South Miami Blvd, Morrisville, NC 27560, United States
    • ,
  • Robert A. Rosenheck

      Affiliations

    • Epidemiology and Public Health, Yale Medical School, United States
    • Child Study Center, Yale Medical School, United States
    • Northeast Program Evaluation Center, VA Connecticut Health Care System, 950 Campbell Ave, West Haven, CT 06516, United States
    • ,
  • Gail L. Daumit

      Affiliations

    • Epidemiology, and Health Policy and Management, Johns Hopkins Medical Institutions, 2024 East Monument Street, Suite 2-500, Baltimore, MD 21287, United States
    • ,
  • John Hsiao

      Affiliations

    • Adult Psychopharmacology Intervention Program, National Institute of Mental Health, Bethesda, MD, United States
    • ,
  • Marvin S. Swartz

      Affiliations

    • Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Box 3173, Duke University Medical Center, Durham, NC 27710, United States
    • ,
  • T. Scott Stroup

      Affiliations

    • Department of Psychiatry, University of North Carolina at Chapel Hill, Campus Box 7160, Chapel Hill, NC 27599-7160, United States
    • ,
  • Jeffrey A. Lieberman

      Affiliations

    • Department of Psychiatry, Columbia University, Psychiatric Institute, 1051 Riverside Drive, New York, NY 10032, United States

Received 1 September 2007 ,Revised 6 December 2007 ,Accepted 22 December 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Supported by NIMH grant #N01MH90001.

PII: S0920-9964(08)00038-8

doi: 10.1016/j.schres.2007.12.487

Schizophrenia Research
Volume 101, Issue 1 , Pages 273-286 , April 2008

Article Tools

* Image Usage & Resolution